OnKure Therapeutics, Inc.
OKUR
$2.60
-$0.02-0.76%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -42.00% | -- | -- | -- | |
| Total Depreciation and Amortization | 44.39% | -- | -- | -- | |
| Total Amortization of Deferred Charges | -89.06% | -- | -- | -- | |
| Total Other Non-Cash Items | 439.45% | -- | -- | -- | |
| Change in Net Operating Assets | -274.54% | -- | -- | -- | |
| Cash from Operations | -83.05% | -- | -- | -- | |
| Capital Expenditure | 25.71% | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -- | -- | |
| Cash from Investing | 22,775.71% | -- | -- | -- | |
| Total Debt Issued | -100.00% | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 173,082.35% | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | 36,473.76% | -- | -- | -- | |
| Cash from Financing | 1,769.49% | -- | -- | -- | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 315.37% | -- | -- | -- | |